SMS Lifesciences India's Q1 FY 2025-26 Quarter Results

Result Summary

• SMS Lifesciences India Ltd reported a 9.6% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 10.2%.
• Its expenses for the quarter were down by 10.3% QoQ and 7.1% YoY.
• The net profit decreased 32.1% QoQ and decreased 38.2% YoY.
• The earnings per share (EPS) of SMS Lifesciences India Ltd stood at 13.8 during Q1 FY 2025-26.

Financial Statments for Q1 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

SMS Lifesciences India Ltd operates within the pharmaceutical industry, focusing primarily on the manufacturing and development of active pharmaceutical ingredients (APIs). The company engages in a range of activities including research and development, production, and sales of pharmaceutical products. As a player in the pharmaceutical sector, SMS Lifesciences India Ltd potentially deals with various regulatory frameworks and competitive market dynamics. However, specific recent developments or strategic initiatives undertaken by the company are not provided in the available data.

Revenue

In the first quarter of fiscal year 2026 (Q1FY26), SMS Lifesciences India Ltd reported a total income of ₹83.50 crores. This represents a decrease of 9.6% compared to the previous quarter (Q4FY25), where total income was ₹92.35 crores, and a 10.2% decrease year-over-year from Q1FY25, which recorded a total income of ₹92.99 crores. This decline in revenue on both a quarterly and annual basis may reflect changes in market conditions, product demand, or other operational factors impacting sales.

Profitability

During Q1FY26, the company reported a profit before tax of ₹7.02 crores, which is a slight decrease of 1.1% from the previous quarter's figure of ₹7.10 crores. Compared to the same quarter last year (Q1FY25), the profit before tax has decreased by 34.0% from ₹10.64 crores. The tax expense for Q1FY26 was ₹2.64 crores, a significant increase of 319.0% from Q4FY25's tax expense of ₹0.63 crores, though it is a decrease of 25.4% from Q1FY25's tax expense of ₹3.54 crores. Consequently, the profit after tax for Q1FY26 was ₹4.39 crores, down from ₹6.47 crores in Q4FY25 and ₹7.10 crores in Q1FY25, reflecting declines of 32.1% and 38.2% respectively.

Operating Metrics

The company's earnings per share (EPS) for Q1FY26 were ₹13.80, showing a decline of 29.2% from the previous quarter's EPS of ₹19.50 and a decrease of 40.3% from the EPS of ₹23.10 reported in Q1FY25. The total expenses for Q1FY26 amounted to ₹76.48 crores, a decrease of 10.3% from Q4FY25's expenses of ₹85.25 crores, and a 7.1% decrease compared to Q1FY25's expenses of ₹82.34 crores. These changes in expenses alongside the revenue and profitability figures suggest shifts in cost management and operational efficiency, though specific reasons for these changes are not detailed in the provided data.